Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy

Published:2023-11 Issue:6 Volume:158 Page:
ISSN:2784-8671
Container-title:Italian Journal of Dermatology and Venereology
language:
Short-container-title:Ital J Dermatol Venereol

Author:

LICATA Gaetano,TANCREDI Vittorio,GAMBARDELLA Alessio,MEGNA Matteo,FABBROCINI Gabriella,RAIMONDO Annunziata,LEMBO Serena,LIGRONE Luigi,CUSANO Francesco,ARGENZIANO Giuseppe

Publisher

Edizioni Minerva Medica

Subject

Infectious Diseases,Dermatology

Link

https://www.minervamedica.it/pdf.php?cod=R23Y2023N06A0452

Reference16 articles.

1. Psoriasis

2. Apremilast: A Review in Psoriasis and Psoriatic Arthritis

3. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

4. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

5. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP